Showing results (361-370 of 541) with videos related to

Sort By:
Pageof 55
Antiviral Therapy|April 9, 2015
Low risk of lamivudine-resistant HBV and hepatic flares in treated HIV-HBV-coinfected patients from Côte d'IvoireAnders Boyd, Raoul Moh, Delphine Gabillard, et al.
Molecular Cell|January 24, 2002
DNA damage-dependent acetylation of p73 dictates the selective activation of apoptotic target genesAntonio Costanzo, Paola Merlo, Natalia Pediconi, et al.
AIDS (London, England)|January 28, 2006
Major role of hepatitis B genotypes in liver fibrosis during coinfection with HIVKarine Lacombe, Véronique Massari, Pierre-Marie Girard, et al.
Hepatology (Baltimore, Md.)|August 5, 2015
Present and future therapies of hepatitis B: From discovery to cureT Jake Liang, Timothy M Block, Brian J McMahon, et al.
Clinics and Research in Hepatology and Gastroenterology|March 20, 2018
Anti-E1E2 antibodies status prior therapy favors direct-acting antiviral treatment efficacyVictor Virlogeux, Pascale Berthillon, Isabelle Bordes, et al.
Microbial Genomics|May 18, 2021
Cas9-targeted nanopore sequencing reveals epigenetic heterogeneity after de novo assembly of native full-length hepatitis B virus genomesChloe Goldsmith, Damien Cohen, Anaëlle Dubois, et al.
Scientific Reports|May 31, 2018
Combining amplicon sequencing and metabolomics in cirrhotic patients highlights distinctive microbiota features involved in bacterial translocation, systemic inflammation and hepatic encephalopathyValerio Iebba, Francesca Guerrieri, Vincenza Di Gregorio, et al.
Hepatology (Baltimore, Md.)|February 1, 2012
High plasma level of nucleocapsid-free envelope glycoprotein-positive lipoproteins in hepatitis C patientsCaroline Scholtes, Christophe Ramière, Dominique Rainteau, et al.
AIDS (London, England)|August 11, 2020
Correlation of serum hepatitis B core-related antigen with hepatitis B virus total intrahepatic DNA and covalently closed circular-DNA viral load in HIV-hepatitis B coinfectionLorenza N C Dezanet, Sarah Maylin, Audrey Gabassi, et al.
Journal of Hepatology|June 3, 2014
Role of a 48-week pegylated interferon therapy in hepatitis B e antigen positive HIV-co-infected patients on cART including tenofovir: EMVIPEG studyPatrick Miailhes, Marianne Maynard-Muet, Fanny Lebossé, et al.
Pageof 55